Evidence map›Paper›PMID 29488881›Full record

ArticleeLife2018

Explosive mutation accumulation triggered by heterozygous human Pol ε proofreading-deficiency is driven by suppression of mismatch repair.

Karl P Hodel, Richard de Borja, Erin E Henninger, Brittany B Campbell, Nathan Ungerleider, Nicholas Light, Tong Wu, Kimberly G LeCompte, A Yasemin Goksenin, Bruce A Bunnell and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Cancers from NovelCancer research · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Karl P Hodel *Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, United States.
Richard de Borja *Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Erin E Henninger *Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, United States.
Brittany B CampbellThe Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
Nathan UngerleiderDepartment of Pathology, Tulane University School of Medicine, New Orleans, United States.
Nicholas LightProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Tong WuDepartment of Pathology, Tulane University School of Medicine, New Orleans, United States.
Kimberly G LeCompteDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, United States.
A Yasemin GokseninDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, United States.
Bruce A BunnellDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, United States.
Uri TaboriProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Adam ShlienProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Zachary F PursellDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, United States.ORCID 0000-0001-5871-7192
Tulane University · USHospital for Sick Children · CAUniversity of Toronto · CA

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBPP20RR020152 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI YOU, ZONGBING · 2004 to 2011
$17.0M
Investigation of human DNA polymerase epsilon variantsR01ES028271 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI Zachary F Pursell · 2017 to 2026
$3.6M
Control of Genome Stability by Replicative DNA PolymerasesR01CA129925 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAVLOV, YOURI I · 2008 to 2012
$1.2M
Roles of Human DNA Polymearse Epsilon in Mutagenesis and Genome StabilityR00ES016780 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI PURSELL, ZACHARY F · 2009 to 2011
$746k
Mutagenesis, tumorigenesis and human DNA polymerase epsilonR56ES026821 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI PURSELL, ZACHARY F · 2016 to 2016
$150k
NCRR NIH HHS NIH P20 RR020152NCRR NIH HHS P20 RR020152NIEHS NIH HHS NIH R00 ES016780NIEHS NIH HHS NIH R01ES028271NIEHS NIH HHS NIH R56ES026821NIEHS NIH HHS R00 ES016780NIEHS NIH HHS R01 ES028271NIEHS NIH HHS R56 ES026821NIH HHS P51 OD011104
6 · The paper itself

Abstract

Tumors defective for DNA polymerase (Pol) ε proofreading have the highest tumor mutation burden identified. A major unanswered question is whether loss of Pol ε proofreading by itself is sufficient to drive this mutagenesis, or whether additional factors are necessary. To address this, we used a combination of next generation sequencing and in vitro biochemistry on human cell lines engineered to have defects in Pol ε proofreading and mismatch repair. Absent mismatch repair, monoallelic Pol ε proofreading deficiency caused a rapid increase in a unique mutation signature, similar to that observed in tumors from patients with biallelic mismatch repair deficiency and heterozygous Pol ε mutations. Restoring mismatch repair was sufficient to suppress the explosive mutation accumulation. These results strongly suggest that concomitant suppression of mismatch repair, a hallmark of colorectal and other aggressive cancers, is a critical force for driving the explosive mutagenesis seen in tumors expressing exonuclease-deficient Pol ε.

Indexed as

DNA Mismatch RepairMutation AccumulationCell Line, TumorColorectal NeoplasmsDNA Polymerase IIHumansDNA Polymerase IIbiochemistrycancer biologychemical biologyDNA PolymeraseDNA ReplicationGenome StabilityhumanMutagenesis

Identifiers

PMID29488881
PMCPMC5829921
OpenAlexW2788377084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.